Table 4 Frequency of drug classes in long-term medication being involved in rPDDI and the respective interaction propensity; n = 136
Drug class (ATC code level 2) | Number of detected interactions | Interaction propensity |
|---|---|---|
Agents acting on the renin-angiotensin system (C09) | 17 | 0.26 |
Beta blocking agents (C07) | 13 | 0.26 |
Antithrombotic agents (B01) | 13 | 0.19 |
Corticosteroids for systemic use (H02) | 12 | 0.75 |
Drugs used in diabetes (A10) | 12 | 0.41 |
Lipid modifying agents (C10) | 11 | 0.23 |
Diuretics (C03) | 9 | 0.15 |
Cardiac therapy (C01) | 9 | 1.0 |
Calcium channel blockers (C08) | 8 | 0.27 |
Drugs for obstructive airway diseases (R03) | 6 | 0.25 |
Others | 32 | - |